HMPAO SPECT to assess neurologic deficits during balloon test occlusion by 유영훈 et al.
1996;37:551-554.J Nucl Med. 
  
Sung Lee
Young Hoon Ryu, Tae Sub Chung, Jong Doo Lee, Dong Ik Kim, Jung Ho Suh, Chang Yun Park, Won Sang Lee and Kyu
  
HMPAO SPECT to Assess Neurologic Deficits during Balloon Test Occlusion
 http://jnm.snmjournals.org/content/37/4/551
This article and updated information are available at: 
  
 http://jnm.snmjournals.org/site/subscriptions/online.xhtml
Information about subscriptions to JNM can be found at: 
  
 http://jnm.snmjournals.org/site/misc/permission.xhtml
Information about reproducing figures, tables, or other portions of this article can be found online at: 
(Print ISSN: 0161-5505, Online ISSN: 2159-662X)
1850 Samuel Morse Drive, Reston, VA 20190.
SNMMI | Society of Nuclear Medicine and Molecular Imaging
 is published monthly.The Journal of Nuclear Medicine
© Copyright 1996 SNMMI; all rights reserved.
by Yonsei University - Medical Library on September 23, 2014. For personal use only. jnm.snmjournals.org Downloaded from 
METHODS
Pa@nts
The studypopulationconsisted of24 patientswith varioushead and
skull base tumors: 6 patients with pituitary tumor, 5 with thyroid
carcinoma, 4 with mucoepidermoid carcinoma, 3 with angiofibroma.
3 with meningioma,2 with massivejugulodigasniclymph node
metastasis and one with osteogenic sarcoma of the maxilla. All
patients had the possibility ofaccidental ligation ofthe internal carotid
artery during operation because ofclose contact with the tumor mass.
We first performed cerebral angiography with contralateral carotid
artery compression to evaluate the circle of Willis. The posterior
communicating artery was assessed by carotid artery compression
during vertebral angiography. Balloon occlusion ofthe internal carotid
artery using a 5 French Swan-Ganz catheter through a 7 French
Hemaquet introducer sheath was applied and the balloon was filled
with contrast material. Occlusion was performed at the mid-cervical
internal carotid artery level to avoid carotid body stimulation and
petrosal segment ofICA injury by the catheter's stiffballoon segment
Ballooning was continued until its pulsatile motion from the cardiac
cycle ceased. Neurologic examination of the patients was performed
during the occlusion. Fifteen minutes after internal carotid artery
balloon test occlusion, 20 mCi (740 M&i) of @Fc-HMPAOwere
injected intravenously. The test occlusion was maintained for an
additional 15 mm (a total of 30 mm), as long as patients remained
without deficit on clinical neurologic examination. Patients were then
transferred to the nuclear medicine department for cerebral SPECT
images, which were obtained with the Siemens orbiter 7500 gamma
camera. Sixty-four views were taken during 360Â°rotation about the
long axis ofthe patients. A 64 X 64 matrix (pixel size 6.25 mm) was
used; axial and coronal reconstruction was done by Microdelta
computer. Occlusion study results were compared to those of the
preocciusion study taken at least 3 days before the balloon occlusion
test using the semiquantitative method. Semiquantitative analysis was
performed using mirror technique, with regions of interest (ROIs)
drawn on both middle cerebral artery (MCA) terntories. Relative






























ing five patientsshowedsevereneurologk@symptoms,such as
transienthemiplegiandunconsciousness.Thecomparativeuptake
of theirmkidlecerebralarteryterritorieswas 77%-85% of the










extensive tumors involving the neck or skull base may require
occlusion of the internal carotid artery. The circle of Willis
provides collateral circulation for the territory of the occluded
internal carotid artery but is completely intact in only 21% of
patients (1 ). Permanent occlusion or surgical sacrifice of the
internal carotid arteiy may cause subsequent stroke (2), which
ofteninvolves largevascularterritoriesandin some cases is lethal.
Balloon test occlusion of the internal cerebral artery with
monitoring of clinical neurologic status has been used to identify
patients who might develop ischemia and infarction with perma
nent occlusion (3â€”5).Five percent to 20% of patients with no
clinical signs of ischemia during balloon test occlusion develop an
infarction with permanent occlusion. A method using @mTc@
HMPAOto identifypatientswho clinicallypassaninternalcarotid
artery balloon test occlusion but who then may develop a cerebral
infarction after permanent occlusion has been described (2,6â€”8).
In this study, we assessed the feasibility of using @mTC@
HMPAObrainSPECTto objectively andpreoperativelypredict
neurologic deficits from the permanent occlusion of an internal
carotid artery.
Received Feb. 14, 1995; revisionaccepted Aug. 18, 1995.
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Additional tests included neurological examination to classify
patients into clinically tolerated and clinically not tolerated groups,
electroencephalography, intracarotid stump pressure monitoring
and cerebralangiography with contralateralcarotid arterycompres
sion, which were compared to the brain SPECT findings.
RESULTS
Clinical neurologic examination during the 30 mm of internal
carotid artery balloon test occlusion showed 19 patients with no
evidence of ischemia and 5 with abnormalities. In the clinically
not tolerated group 4 patients developed motor weakness, 3
sudden loss of consciousness, 3 sensory changes and 3 abnor
mal EEG changes.
The clinically tolerated group and the clinically not tolerated
group had postocclusion mean stump pressures of 55 to 85
mmHg and 30 to 60 mmHg, respectively; mean stump pressure
decreases of 10 to 45 mmHg and 30 to 70 mmH@,respectively;
and relative percentage of MCA territory of@ mlc-HMPAO
SPECT was 95%â€”lOl%and 77%â€”85%,respectively (Table 1).
Technetium-99m-HMPAO brain SPECT showed more perfu
sion deficits in the clinically not tolerated group than in the
clinically tolerated group (Figs. I, 2). Asymmetrical cerebral
hypoperfusion on wmTc@HMPAO SPECT with angiographic
evidence of good cross-filling from the nonoccluded to the
occluded side was demonstrated in two patients (Fig. 3).
DISCUSSION
Permanent occlusion of the internal carotid artery is a
recognized treatment for certain intracranial aneurysms and
extensive tumors involving neck and skull base when there is
adequate collateral cerebral circulation (9, 10). A previous
report, however, demonstrated that occlusion of the common
carotid artery or internal carotid artery carries about 30% risk of
ischemia of the ipsilateral cerebral hemisphere (9 ). In 2 1% of
the cases, onset of deficits is delayed for more than 48 hr after
occlusion. It is thought that infarction after successful tempo
rary and permanent carotid occlusion has two basic causes: (a)
hypoperfusion and ischemia due to inadequate collaterals
around the circle of Willis and (b) the cardiovascular status of
the patient (6,8). The hypoperfusion problem is definitely more
serious in the elderly, whose blood pressure and cardiac output
are less stable, than in younger patients (6 ). The other major
cause is embolism, from a clot developing in the occluded
supraclinoid carotid artery stump and then becoming dislodged
and entering the middle cerebral artery circulation (6â€”8,11).
To assess collateral circulation adequacy during the internal
carotid artery occlusion test, various techniques have been








extensionto nghtparasellararea (B) @j@itt@1@ on AP projection
shows good visualizationof contralateralmiddler@L@i arterythrough the
anteÃ±orcommunkating arteryduring leftcarotid @r@@C) Preocclu
sion brainSPECTshows no significant@ @t@; betweenthe
cerebral hemispheres.(D) Postoccluskn@ SPECT shows markedly
decreasedperfusionon the nght cerebral@ Semiquantitative
analytis revealedmore than 15% perfusion@
raphy (EEG) (13,14), somatosensory evoked potentials (SEPs)
(15), stumppressure(16,17), transcranialdoppler(18), â€˜33Xe
with external probes (13, 17), stable xenon with CT (3,19,20)
and PET (21 ). Stump pressure measurement correlates with
intracranial blood flow, but the wide normal value range
precludes its use as an absolute predictor of adequate cerebral
blood flow and it is available only at a few institutions (4,16).
A PET scan during the test occlusion period would be techni
cally difficult (21 ). External probe measurement with â€˜33Xeis
easy to perform in the angiography suite and offers reproducible
quantitative measurements, but it does not provide regional
perfusion information. Stable xenon CT cerebral blood flow
imaging with balloon test occlusion may reveal focal areas of
ischemia that are clinically indiscernible, but it requires special
added features for the CT scanner (6).
Matsuda et al. have used 99mTc@HMPAOSPECT to assess
cerebral perfusion during test occlusion of the carotid artery
(22). Technetium-99m-HMPAO is a lipophilic radiotracer with
an extraction across the blood-brain barrier ofabout 0.75. Once
inside the brain, it is rapidly converted into a hydrophilic form
that is retained for hours. The contrast between normal and
abnormal brain remains constant for I0 mm to 2 hr. As 99mTc
has a half-life of 6 hr, 99mTc@HMPAOSPECT studies may be
repeated the next day to determine if a perfusion defect is
reversible and related to the balloon test occlusion (23,24).
Results ofa study by Monsein et al. suggest that patients who
had no changes between baseline and test occlusion @mTc@
HMPAOSPECTstudies should have adequatecollateralcircu
lation to sustain cerebral blood flow after occlusion of the
internal carotid artery ifno thromboembolic episodes occur (7).
Similar reports on internal carotid occlusion with 99mTc..
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FIGURE2@A 31-yr-oldwomanwithpituitaryadenoma. @A)xialCTscan
shows pituitarytumor encirclingthe leftcarotidartery.(B)Carotidangiogram
onAPprojectionshowsnonvisualizationoftherightmiddlecerebralartery
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perfusionon antenorand posterioraspectof the righthenÃ¼sphere.
no way to objectively predict which patients will not tolerate
internal carotid occlusion because of thromboembolic compli
cations.
CONCLUSION
Although the patient number was small and postoperative
follow-up was scanty, our results suggest that @mTc@HMPAO
brain SPECT before and during balloon test occlusion is a
simple and objective method for predicting permanent neuro
logic deficits when the comparative uptake of middle cerebral
artery territories during balloon test occlusion is less than 85%
of that before balloon test occlusion.
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the neurochemical changes accompanying normal aging. Aging
is associated with changes in several neurotransmitters (2) as
well as changes in specific motor, cognitive and emotional
behaviors (3). The dopaminergic system appears to be among
the most age-sensitive neurotransmitters (4). Of the behavioral
changes associated with aging, the most conspicuous are those
related to motonc function. For example, aging is associated
with a higher frequency of dyskinesias (5â€”6)and of mild
Parkinson-like motor changes such as rigidity (7). Some of
these motoric changes may reflect an age related decline in
nigrostriatal dopaminergic function (8).
Studies in animals as well as postmortem human brain
studies, have in general documented a decline in brain dopa
mine activity with aging (9, 10). Recently, imaging techniques
such as PET and SPECT have enabled the measurement of
changes in dopamine parameters as a function of age in living
human subjects. Most of these studies have focused on dopa
mine receptors and have documented a decrease in D2 and Dl
receptor density with aging (11â€”18).Changes in dopamine
receptors, however, predominantly reflect changes in postsyn
aptic elements presumably GABAergic, muscarmnicand gluta
matergic neurons and not changes in dopaminergic neurons.
Few studies have been conducted on age-related changes in
dopamine neurons in living human subjects. Age changes in the
dopamine neurons of living human subjects have been studied,
using PET and SPECT tracers, to measure dopamine metabo
lism and dopamine transporter sites. Studies using [18F]fluoro
DOPA to measure dopamine metabolism have been inconclu
sive documenting reduced uptake (19) as well as no changes
(20,21). Preliminarystudiesusing @l1C]nomifensine(22),
[1 â€˜C]cocaine (23 ) and [â€˜23I]@3-CIT (24) as ligands for the
Postmortem studies have documented degenerationof dopamine
cells with age, but the changes that occur in healthyaging indMd
uals is lessclear.The purposeof this studywas to evaluatethe
extent to which age-induced changes in doparnine transporters
occur in subjects with no evidence of motor impairment. Methods
Weevaluated23right-handedhealthyvolunteers(agerange20-74
yr) usingPETand r1c]d-th@O-msthyIPhanidate.The ratioof the
distributionvolumefor r1c1d-th@-mefh@be@*istein striatumto
that in cerebellumwas usedas modelparameterfordopamine
transporteravailability(Bmax/Kd+ 1).Results Dopaminetrans
porteravalIabift@,wassignificantlylowerin subjects>40 yr of age
thaninthose<40 yr.Estimatesof dopaminetransporteravailability
showed a signfficant negative correlation with age both for the
putamen (r = â€”0.72,p < 0.0001)and the caudate (r = â€”0.74,p <
0.0001).Doparninetransporter availat@litywas higherin the left than
in the rightputamenbut did not differbetweenthe leftand right
caudate. Conclusion: This study documents a 6.6% decreaseper
decade of life in striatal dopamine transporters of healthy volun
tears.
Key Words PET; dopamine transporters; degeneration
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AccordingtoprojectionsbytheU.S.BureauoftheCensus,
the number of individuals 65 yr and older will more than double
by the middle ofthe next century to nearly 79 million. Whereas
about 1 in 8 Americans were elderly in 1990, about 1 in 5 could
be elderly in the year 2030 (1 ). This progressive increase in the
elderly population places a sense of urgency on understanding
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